100% Quality Guarantee
PhD-Level Technical Support
Human CD152/CTLA4 Recombinant Protein (C-His)
Key Features

Human CD152/CTLA4 Recombinant Protein (C-His) (GXRP01041)

SKU GXRP01041
Product Type Recombinant Protein
Species Human
Expression System Mammalian cells
Tag C-His
Purity >90% as determined by SDS-PAGE.
$577 - $4,138

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Human CD152/CTLA4 Recombinant Protein (C-His)

Human CD152/CTLA4 Recombinant Protein (C-His) is a recombinant protein expressed in mammalian cells, spanning Met1-Asp161, with a C-terminal His tag. Predicted molecular weight: 18.55 kDa. Purity: >90% as determined by SDS-PAGE. Supplied lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol. Applications: ELISA, immunogen, SDS-PAGE and Western blot. Cytotoxic T-lymphocyte protein 4 (CD152/CTLA4) is a ~24 kDa protein. Inhibitory receptor acting as a major negative regulator of T-cell responses. For research use only.

Acts as a decoy receptor: the affinity of CTLA4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory coreceptor CD28. CD152 is the therapeutic target of ipilimumab (Yervoy).

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose